TB drugs interact adversely with protease inhibitors.
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy; D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy / Q000821:virology*; D000995:Antitubercular Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004347:Drug Interactions; D006678:HIV / Q000302:isolation & purification; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D010349:Patient Compliance; D012294:Rifamycins / Q000009:adverse effects* / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary; D014766:Viremia
D000995:Antitubercular Agents; D017320:HIV Protease Inhibitors; D012294:Rifamycins